These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20822904)

  • 81. Antimalarial evaluation and docking studies of hybrid phenylthiazolyl-1,3,5-triazine derivatives: a novel and potential antifolate lead for Pf-DHFR-TS inhibition.
    Gahtori P; Ghosh SK; Parida P; Prakash A; Gogoi K; Bhat HR; Singh UP
    Exp Parasitol; 2012 Mar; 130(3):292-9. PubMed ID: 22233734
    [TBL] [Abstract][Full Text] [Related]  

  • 82. In vitro antimalarial activity and molecular docking analysis of 4-aminoquinoline-clubbed 1,3,5-triazine derivatives.
    Bhat HR; Ghosh SK; Prakash A; Gogoi K; Singh UP
    Lett Appl Microbiol; 2012 May; 54(5):483-6. PubMed ID: 22394198
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Benzoxaborole antimalarial agents. Part 4. Discovery of potent 6-(2-(alkoxycarbonyl)pyrazinyl-5-oxy)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles.
    Zhang YK; Plattner JJ; Easom EE; Jacobs RT; Guo D; Sanders V; Freund YR; Campo B; Rosenthal PJ; Bu W; Gamo FJ; Sanz LM; Ge M; Li L; Ding J; Yang Y
    J Med Chem; 2015 Jul; 58(13):5344-54. PubMed ID: 26067904
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Discovery and development of 2-aminobenzimidazoles as potent antimalarials.
    Devine SM; Challis MP; Kigotho JK; Siddiqui G; De Paoli A; MacRaild CA; Avery VM; Creek DJ; Norton RS; Scammells PJ
    Eur J Med Chem; 2021 Oct; 221():113518. PubMed ID: 34058708
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Structure activity refinement of phenylsulfonyl piperazines as antimalarials that block erythrocytic invasion.
    Nguyen W; Dans MG; Ngo A; Gancheva MR; Romeo O; Duffy S; de Koning-Ward TF; Lowes KN; Sabroux HJ; Avery VM; Wilson DW; Gilson PR; Sleebs BE
    Eur J Med Chem; 2021 Mar; 214():113253. PubMed ID: 33610028
    [TBL] [Abstract][Full Text] [Related]  

  • 86. In vitro efficacy of 2,N-bisarylated 2-ethoxyacetamides against Plasmodium falciparum.
    Gutteridge CE; Major JW; Nin DA; Curtis SM; Bhattacharjee AK; Gerena L; Nichols DA
    Bioorg Med Chem Lett; 2016 Feb; 26(3):1048-1051. PubMed ID: 26750257
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Discovery of Potent and Fast-Acting Antimalarial Bis-1,2,4-triazines.
    Priebbenow DL; Mathiew M; Shi DH; Harjani JR; Beveridge JG; Chavchich M; Edstein MD; Duffy S; Avery VM; Jacobs RT; Brand S; Shackleford DM; Wang W; Zhong L; Lee G; Tay E; Barker H; Crighton E; White KL; Charman SA; De Paoli A; Creek DJ; Baell JB
    J Med Chem; 2021 Apr; 64(7):4150-4162. PubMed ID: 33759519
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Facile synthesis of antimalarial 1,2-disubstituted 4-quinolones from 1,3-bisaryl-monothio-1,3-diketones.
    Vinayaka AC; Sadashiva MP; Wu X; Biryukov SS; Stoute JA; Rangappa KS; Gowda DC
    Org Biomol Chem; 2014 Nov; 12(42):8555-61. PubMed ID: 25245989
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Synthesis of solution-phase combinatorial library of 4,6-diamino-1,2-dihydro-1,3,5-triazine and identification of new leads against A16V+S108T mutant dihydrofolate reductase of Plasmodium falciparum.
    Vilaivan T; Saesaengseerung N; Jarprung D; Kamchonwongpaisan S; Sirawaraporn W; Yuthavong Y
    Bioorg Med Chem; 2003 Jan; 11(2):217-24. PubMed ID: 12470716
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Synthesis of carbocyclic pyrimidine nucleosides and their inhibitory activities against Plasmodium falciparum thymidylate kinase.
    Noguchi Y; Yasuda Y; Tashiro M; Kataoka T; Kitamura Y; Kandeel M; Kitade Y
    Parasitol Int; 2013 Aug; 62(4):368-71. PubMed ID: 23583697
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Design, synthesis and antimalarial screening of some hybrid 4-aminoquinoline-triazine derivatives against pf-DHFR-TS.
    Sahu S; Ghosh SK; Kalita J; Dutta M; Bhat HR
    Exp Parasitol; 2016 Apr; 163():38-45. PubMed ID: 26821296
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Aminoazabenzimidazoles, a novel class of orally active antimalarial agents.
    Hameed P S; Chinnapattu M; Shanbag G; Manjrekar P; Koushik K; Raichurkar A; Patil V; Jatheendranath S; Rudrapatna SS; Barde SP; Rautela N; Awasthy D; Morayya S; Narayan C; Kavanagh S; Saralaya R; Bharath S; Viswanath P; Mukherjee K; Bandodkar B; Srivastava A; Panduga V; Reddy J; Prabhakar KR; Sinha A; Jiménez-Díaz MB; Martínez MS; Angulo-Barturen I; Ferrer S; Sanz LM; Gamo FJ; Duffy S; Avery VM; Magistrado PA; Lukens AK; Wirth DF; Waterson D; Balasubramanian V; Iyer PS; Narayanan S; Hosagrahara V; Sambandamurthy VK; Ramachandran S
    J Med Chem; 2014 Jul; 57(13):5702-13. PubMed ID: 24914738
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The antimalarial triazine WR99210 and the prodrug PS-15: folate reversal of in vitro activity against Plasmodium falciparum and a non-antifolate mode of action of the prodrug.
    Kinyanjui SM; Mberu EK; Winstanley PA; Jacobus DP; Watkins WM
    Am J Trop Med Hyg; 1999 Jun; 60(6):943-7. PubMed ID: 10403325
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Synthesis and Antiplasmodial Evaluation of Analogues Based on the Tricyclic Core of Thiaplakortones A-D.
    Schwartz BD; Coster MJ; Skinner-Adams TS; Andrews KT; White JM; Davis RA
    Mar Drugs; 2015 Sep; 13(9):5784-95. PubMed ID: 26389920
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Selective anti-malarial minor groove binders.
    Scott FJ; Khalaf AI; Duffy S; Avery VM; Suckling CJ
    Bioorg Med Chem Lett; 2016 Jul; 26(14):3326-3329. PubMed ID: 27212070
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Phenoxypropoxybiguanides, prodrugs of DHFR-inhibiting diaminotriazine antimalarials.
    Jensen NP; Ager AL; Bliss RA; Canfield CJ; Kotecka BM; Rieckmann KH; Terpinski J; Jacobus DP
    J Med Chem; 2001 Nov; 44(23):3925-31. PubMed ID: 11689078
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Medicinal chemistry discoveries among 1,3,5-triazines: recent advances (2000-2013) as antimicrobial, anti-TB, anti-HIV and antimalarials.
    Patel RV; Keum YS; Park SW
    Mini Rev Med Chem; 2014; 14(9):768-89. PubMed ID: 24958216
    [TBL] [Abstract][Full Text] [Related]  

  • 98. 3,3'-Disubstituted 5,5'-Bi(1,2,4-triazine) Derivatives with Potent in Vitro and in Vivo Antimalarial Activity.
    Xue L; Shi DH; Harjani JR; Huang F; Beveridge JG; Dingjan T; Ban K; Diab S; Duffy S; Lucantoni L; Fletcher S; Chiu FCK; Blundell S; Ellis K; Ralph SA; Wirjanata G; Teguh S; Noviyanti R; Chavchich M; Creek D; Price RN; Marfurt J; Charman SA; Cuellar ME; Strasser JM; Dahlin JL; Walters MA; Edstein MD; Avery VM; Baell JB
    J Med Chem; 2019 Mar; 62(5):2485-2498. PubMed ID: 30715882
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Optimization of 1,2,3,4-tetrahydroacridin-9(10H)-ones as antimalarials utilizing structure-activity and structure-property relationships.
    Cross RM; Maignan JR; Mutka TS; Luong L; Sargent J; Kyle DE; Manetsch R
    J Med Chem; 2011 Jul; 54(13):4399-426. PubMed ID: 21630666
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Synthesis of thiazolyl hydrazonothiazolamines and 1,3,4-thiadiazinyl hydrazonothiazolamines as a class of antimalarial agents.
    Sujatha K; Ommi NB; Mudiraj A; Babu PP; Vedula RR
    Arch Pharm (Weinheim); 2019 Dec; 352(12):e1900079. PubMed ID: 31602690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.